| Name | Title | Contact Details |
|---|---|---|
Lee Hartshorn |
Chief Information Officer | Profile |
Our proprietary software and professional team of CPAs have assisted thousands of businesses retain hundreds of millions of dollars in stimulus funding
As thriving, and in-demand executive leaders, the Churchstreeter and Crosse approach is grounded in catering to our exclusive family of clients. The Executive leaders of Churchstreeter and Crosse envisioned a new way of consulting. They decided that percentage based contracts were great for C&C, but not great for our family of clients. Our goal has always been to create partnerships that withstand the test of time. We transitioned to a bold new style of consulting in order to compete in a space where there was a void. Our annual client engagements are exclusive, and we dont compete within the same space, when we have an exclusive agreement. Our goal has never been to be the biggest, our goal is simply to be the best. With a waiting list of engagements, we know that we have created an amazing value proposition. Our engagement assessment is comprehensive. You will feel the difference immediately. The Churchstreeter and Crosse comprehensive proposal process includes a project plan with timeline, milestones, cost/benefit analysis, and a clear financial agreement based on your goals. We also offer a suite of quality products that will help you get there, quickly and smoothly. Thats how we ensure your success. Our Mission: To deliver the best to our exclusive family of clients and retain the most specialized talent.
You can count on Rushlight Ventures to maximize the value of your intellectual property (IP). Rushlight Ventures is a leading venture studio that specializes in the monetization of defense and dual-use intellectual property created by small and mid-sized businesses conducting federally sponsored research. We are both "IP type" and "monetization path" agnostic. We can pursue value creation from your IP via licenses, asset sales, startups, joint ventures, M&A, or internal business units. We work with IP of all varieties, including products, patents, trade secrets, proprietary relationships, and know-how. At Rushlight Ventures, we provide a range of consulting and support services, including: • Licensing • Asset sales • Joint ventures • Startup and spin-out creation • Commercialization planning and TABA support Companies primarily focused on delivering high-quality research, development, testing, and evaluation services (RDT&E) and other large programs may find it challenging to be equally adept at technology commercialization. Thats why Rushlight Ventures (RLV) originated as a venture studio in 2020 within Cornerstone Research Group (CRG), its sister company and a renowned government contractor for more than 25 years. Soon after forming the venture studio, leadership realized that CRG was not the only company grappling with transition and monetization difficulties, and RLV was spun off as an independent entity in 2021. Today, RLV successfully bridges the gap between RDT&E and commercialization through its seasoned team. RLV staff possess decades of experience in new technology development and commercialization, aerospace and defense RDT&E, new company formation, financing, licensing, and mergers and acquisitions. We have the knowledge and ability to take you from now to wow.
At POCN, we seek to support the careers and clinical practices of NPs and PAs - Advanced Clinicians by partnering with life science companies who recognize their critical role on the front lines of healthcare. We are the largest network of Advanced Clinicians in the U.S. and strive to support and enable success for them at every turn. POCN provides Advanced Clinicians with an opportunity engine to grow their careers, earn valuable financial incentives, and increase their clinical knowledge and practice productivity. Recognizing the vital relationship between NPs, PAs, and the broader healthcare and life sciences industries, POCN specializes in developing peer–validated programs that include engaging live and virtual events, helpful patient education resources, incentivized market research programs, clinical reference and prescribing tools, promoted speaking opportunities, as well as CME and continuous learning modules on a variety of disease states and therapies.